590 related articles for article (PubMed ID: 21737130)
1. Mosaic analysis with double markers reveals tumor cell of origin in glioma.
Liu C; Sage JC; Miller MR; Verhaak RG; Hippenmeyer S; Vogel H; Foreman O; Bronson RT; Nishiyama A; Luo L; Zong H
Cell; 2011 Jul; 146(2):209-21. PubMed ID: 21737130
[TBL] [Abstract][Full Text] [Related]
2. p53 and NF 1 loss plays distinct but complementary roles in glioma initiation and progression.
Gonzalez PP; Kim J; Galvao RP; Cruickshanks N; Abounader R; Zong H
Glia; 2018 May; 66(5):999-1015. PubMed ID: 29392777
[TBL] [Abstract][Full Text] [Related]
3. Culture conditions tailored to the cell of origin are critical for maintaining native properties and tumorigenicity of glioma cells.
Ledur PF; Liu C; He H; Harris AR; Minussi DC; Zhou HY; Shaffrey ME; Asthagiri A; Lopes MB; Schiff D; Lu YC; Mandell JW; Lenz G; Zong H
Neuro Oncol; 2016 Oct; 18(10):1413-24. PubMed ID: 27106408
[TBL] [Abstract][Full Text] [Related]
4. The cell of origin dictates the temporal course of neurofibromatosis-1 (Nf1) low-grade glioma formation.
Solga AC; Toonen JA; Pan Y; Cimino PJ; Ma Y; Castillon GA; Gianino SM; Ellisman MH; Lee DY; Gutmann DH
Oncotarget; 2017 Jul; 8(29):47206-47215. PubMed ID: 28525381
[TBL] [Abstract][Full Text] [Related]
5. Transformation of quiescent adult oligodendrocyte precursor cells into malignant glioma through a multistep reactivation process.
Galvao RP; Kasina A; McNeill RS; Harbin JE; Foreman O; Verhaak RG; Nishiyama A; Miller CR; Zong H
Proc Natl Acad Sci U S A; 2014 Oct; 111(40):E4214-23. PubMed ID: 25246577
[TBL] [Abstract][Full Text] [Related]
6. MADM gives new insights into gliomagenesis.
Lei L; Canoll P
J Mol Cell Biol; 2011 Oct; 3(5):273-5. PubMed ID: 21926086
[TBL] [Abstract][Full Text] [Related]
7. Dedifferentiation of neurons and astrocytes by oncogenes can induce gliomas in mice.
Friedmann-Morvinski D; Bushong EA; Ke E; Soda Y; Marumoto T; Singer O; Ellisman MH; Verma IM
Science; 2012 Nov; 338(6110):1080-4. PubMed ID: 23087000
[TBL] [Abstract][Full Text] [Related]
8. NG2-cells are not the cell of origin for murine neurofibromatosis-1 (Nf1) optic glioma.
Solga AC; Gianino SM; Gutmann DH
Oncogene; 2014 Jan; 33(3):289-99. PubMed ID: 23318450
[TBL] [Abstract][Full Text] [Related]
9. Olig1/2-Expressing Intermediate Lineage Progenitors Are Predisposed to PTEN/p53-Loss-Induced Gliomagenesis and Harbor Specific Therapeutic Vulnerabilities.
Verma R; Chen X; Xin D; Luo Z; Ogurek S; Xin M; Rao R; Berry K; Lu QR
Cancer Res; 2023 Mar; 83(6):890-905. PubMed ID: 36634201
[TBL] [Abstract][Full Text] [Related]
10. Mouse Models of Pediatric Supratentorial High-grade Glioma Reveal How Cell-of-Origin Influences Tumor Development and Phenotype.
Sreedharan S; Maturi NP; Xie Y; Sundström A; Jarvius M; Libard S; Alafuzoff I; Weishaupt H; Fryknäs M; Larsson R; Swartling FJ; Uhrbom L
Cancer Res; 2017 Feb; 77(3):802-812. PubMed ID: 28115362
[TBL] [Abstract][Full Text] [Related]
11. The nuclear receptor TLX is required for gliomagenesis within the adult neurogenic niche.
Zou Y; Niu W; Qin S; Downes M; Burns DK; Zhang CL
Mol Cell Biol; 2012 Dec; 32(23):4811-20. PubMed ID: 23028043
[TBL] [Abstract][Full Text] [Related]
12. Combinations of genetic mutations in the adult neural stem cell compartment determine brain tumour phenotypes.
Jacques TS; Swales A; Brzozowski MJ; Henriquez NV; Linehan JM; Mirzadeh Z; O' Malley C; Naumann H; Alvarez-Buylla A; Brandner S
EMBO J; 2010 Jan; 29(1):222-35. PubMed ID: 19927122
[TBL] [Abstract][Full Text] [Related]
13. Innate neural stem cell heterogeneity determines the patterning of glioma formation in children.
Lee DY; Gianino SM; Gutmann DH
Cancer Cell; 2012 Jul; 22(1):131-8. PubMed ID: 22789544
[TBL] [Abstract][Full Text] [Related]
14. Glial progenitors as targets for transformation in glioma.
Ilkhanizadeh S; Lau J; Huang M; Foster DJ; Wong R; Frantz A; Wang S; Weiss WA; Persson AI
Adv Cancer Res; 2014; 121():1-65. PubMed ID: 24889528
[TBL] [Abstract][Full Text] [Related]
15. Combination of a ptgs2 inhibitor and an epidermal growth factor receptor-signaling inhibitor prevents tumorigenesis of oligodendrocyte lineage-derived glioma-initiating cells.
Hide T; Takezaki T; Nakatani Y; Nakamura H; Kuratsu J; Kondo T
Stem Cells; 2011 Apr; 29(4):590-9. PubMed ID: 21360625
[TBL] [Abstract][Full Text] [Related]
16. Candidate pathways for promoting differentiation or quiescence of oligodendrocyte progenitor-like cells in glioma.
Dougherty JD; Fomchenko EI; Akuffo AA; Schmidt E; Helmy KY; Bazzoli E; Brennan CW; Holland EC; Milosevic A
Cancer Res; 2012 Sep; 72(18):4856-68. PubMed ID: 22865458
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic signaling is dominant to cell of origin and dictates astrocytic or oligodendroglial tumor development from oligodendrocyte precursor cells.
Lindberg N; Jiang Y; Xie Y; Bolouri H; Kastemar M; Olofsson T; Holland EC; Uhrbom L
J Neurosci; 2014 Oct; 34(44):14644-51. PubMed ID: 25355217
[TBL] [Abstract][Full Text] [Related]
18. Premalignant Oligodendrocyte Precursor Cells Stall in a Heterogeneous State of Replication Stress Prior to Gliomagenesis.
Sutcliffe MD; Galvao RP; Wang L; Kim J; Rosenfeld LK; Singh S; Zong H; Janes KA
Cancer Res; 2021 Apr; 81(7):1868-1882. PubMed ID: 33531372
[TBL] [Abstract][Full Text] [Related]
19. Selective calcium sensitivity in immature glioma cancer stem cells.
Wee S; Niklasson M; Marinescu VD; Segerman A; Schmidt L; Hermansson A; Dirks P; Forsberg-Nilsson K; Westermark B; Uhrbom L; Linnarsson S; Nelander S; Andäng M
PLoS One; 2014; 9(12):e115698. PubMed ID: 25531110
[TBL] [Abstract][Full Text] [Related]
20. Non-stem cell origin for oligodendroglioma.
Persson AI; Petritsch C; Swartling FJ; Itsara M; Sim FJ; Auvergne R; Goldenberg DD; Vandenberg SR; Nguyen KN; Yakovenko S; Ayers-Ringler J; Nishiyama A; Stallcup WB; Berger MS; Bergers G; McKnight TR; Goldman SA; Weiss WA
Cancer Cell; 2010 Dec; 18(6):669-82. PubMed ID: 21156288
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
